Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC
Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC
Active, not recruiting · NCT06895811 · Registry updated 2026-07-23Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Clinical Study of Safety and Efficacy of Universal PSMA CAR- T in Refractory CRPC | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, metastatic prostate carcinoma, neoplasm, prostate cancer, prostate disorder | Active, not recruiting | Phase 1 | 2026-07-23 | NCT06895811 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Bioray Laboratories | 10 |
| Shanghai Changzheng Hospital | 79 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Changzheng hospital | Shanghai | China | 5 |